Medtronic opens Galway software hub for cardiac care

Medtronic has opened a European software development hub in Galway for its Patient Care Systems unit and has begun recruiting for an initial 85 roles.

The site will serve as a global centre for cardiac digital health, with Galway teams focused on software used in the care of patients with implanted cardiac devices.

Roles include leadership, software engineering and systems reliability positions. The Galway operation will work on cloud-based platforms and clinical software designed to connect devices, clinicians and patients in real time.

The move adds a software development function to Medtronic's long-established presence in Ireland, where it has operated in Galway and Westmeath for more than 40 years. Micheál Martin, the Taoiseach, said the company's total investment in Ireland over that period has reached about €11 billion, including €1.2 billion in research and development.

The expansion reflects a broader push by medtech groups to build out software and data operations alongside traditional device manufacturing and engineering. At Medtronic, the Galway hub sits within Patient Care Systems, the part of the business that develops digital platforms for cardiac care from implant through long-term follow-up.

More than 3 million patients currently rely on those systems to stay connected to their care teams. The software supports device programming, remote monitoring, data delivery and clinical insights for clinicians and patients.

Alex Mann outlined the company's plans for the site.

“It gives me great pleasure to announce the establishment of our Patient Care Systems software hub in Galway, which will serve as a key part of our global organisation. This investment reflects our confidence in the exceptional talent, strong engineering heritage and collaborative ecosystem across the West of Ireland. PCS in Galway represents far more than an expansion of our footprint. Our vision is to build an enduring software capability that advances cardiac care, accelerates innovation and delivers solutions that empower clinicians and improve patient outcomes worldwide,” said Alex Mann, vice president of Patient Care Systems at Medtronic.

Government figures used the announcement to underline Ireland's position in medical technology and digital health, particularly in the west of the country, where Galway has long hosted major medtech operations.

“Ireland's position as a global leader in medtech and digital health is built on sustained investment in innovation and people. Medtronic's decision to expand its Patient Care Systems function in Galway, bringing its total investment in Ireland to approximately €11 billion over the last 40 years, including €1.2 billion in research and development, is a strong endorsement of the region's talent base and infrastructure. The immediate creation of 85 high-value jobs will support long-term economic growth in the West of Ireland and provide exciting new career opportunities for local people, including graduates of local universities. It marks a strategic investment in digital innovation in the West of Ireland, with commensurate growth expected over the next three years,” said Micheál Martin, Taoiseach.

Peter Burke, Minister for Enterprise, Tourism and Employment, said the decision reinforced Galway's standing as a location for digital health investment and employment.

“Medtronic's decision to establish a European software hub in Galway further cements the region's reputation as a premier location for digital health innovation. These new roles and its further growth represent more than just high-quality employment: they are a beacon for world-class tech talent in the West. It is incredibly exciting to see Galway attract this hub, which will allow professionals to build global careers while enjoying the unique quality of life the region offers. This investment is also testament to the local medtech ecosystem, which is going from strength to strength,” said Burke.

IDA Ireland backed the move as a sign of continued foreign direct investment into higher-value health technology work in Ireland.

“This announcement marks a significant evolution of Medtronic's longstanding presence in the West and highlights the strength of the region's talent base. Health is a key growth driver in IDA Ireland's strategy, 'Adapt Intelligently', and Ireland is internationally recognised as a global centre of excellence for medical technologies. Medtronic is placing Ireland at the heart of advanced cardiac software development. I wish Medtronic every success and assure the company of IDA Ireland's continued partnership,” said Mary Buckley, executive director of IDA Ireland.

Medtronic employs more than 95,000 people globally and sells products in more than 150 countries. Its cardiac and patient monitoring businesses form part of a wider portfolio that includes surgical robotics, insulin pumps and other medical technologies.

The Galway expansion highlights the growing overlap between medtech and software, as manufacturers invest in remote monitoring, connected devices and data systems that keep patients and clinicians linked beyond hospital visits. The new hub will support more personalised and proactive cardiac care through software development in Ireland.